Emailed the government vaccine strategy task force, in regards to possible treatments, as i see that being more important than the vaccine itself and in particular mesoblasts possible treatment, below was the reply I was sent.
Appreciate your thoughts.
Good morning, Thank you for your enquiry of 8 September 2020 regarding possible treatments for COVID-19. The Australian Government is taking a strong and decisive approach in responding to COVID-19, based on the latest and best medical advice from the Australian Health Protection Principal Committee and the Communicable Diseases Network Australia. On 11 March 2020, the Prime Minister announced a $2.4 billion COVID-19 National Health Plan to support our health system and protect all Australians, including vulnerable groups such as the elderly, people with chronic conditions and Indigenous communities, from COVID-19. As part of the Government’s response, $95 million from the Medical Research Future Fund (MRFF) has been invested in COVID-19 research, including for diagnostics, vaccine development, antiviral development, clinical trials, digital health research infrastructure, the human immune response to COVID-19 infection, community information needs and behavioural responses during outbreaks. Within this investment there is a $25 million COVID-19 clinical trials grant opportunity currently open to provide funding to evaluate new potential treatments for COVID-19. The Australian National COVID-19 Clinical Evidence Taskforce (the Taskforce) is providing high-priority, evidence-based clinical COVID-19 guidelines that are updated weekly with the latest research. The initiative has received $1.5 million of MRFF funding. The Taskforce recommendations and the clinical guidelines may be accessed here: https://covid19evidence.net.au. Currently, the most promising treatments for COVID-19 are Dexamethasone and Remdesivir. The Taskforce recommendation for potential disease-modifying treatments such as the Mesoblast product remestemcel-L, is: for people with COVID-19, do not use other disease-modifying treatments outside of randomised trials with appropriate ethical approval. I trust this information is of assistance. Kind RegardsCOVID-19 Vaccine Strategy TaskforceHealth Economics & Research DivisionDepartment of Health
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
Cell Therapy News/Articles, page-6722
-
- There are more pages in this discussion • 11,308 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.07 |
Change
0.005(0.47%) |
Mkt cap ! $1.216B |
Open | High | Low | Value | Volume |
$1.08 | $1.10 | $1.06 | $3.371M | 3.135M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 45345 | $1.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.07 | 3875 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 45345 | 1.055 |
9 | 193430 | 1.050 |
3 | 44331 | 1.045 |
5 | 117942 | 1.040 |
3 | 53830 | 1.035 |
Price($) | Vol. | No. |
---|---|---|
1.065 | 3875 | 2 |
1.070 | 28953 | 3 |
1.075 | 46564 | 3 |
1.080 | 87551 | 5 |
1.085 | 47614 | 4 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |